Humoral and T Cell Immune Response after Three Doses of mRNA SARS-CoV-2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study

Scientists designed a prospective Italian multicentrer study to assess humoral and T-cell responses to SARS-CoV-2 vaccination in patients with solid tumors, hematological malignancies, neurological disorders and immunorheumatological diseases.